Report Detail

Chemical & Material Global Platinum-based Anticancer APIs Market Research Report 2021

  • RnM4274577
  • |
  • 17 March, 2021
  • |
  • Global
  • |
  • 122 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others

Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other

By Company
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry

Production by Region
North America
Europe
China
India

Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE


1 Platinum-based Anticancer APIs Market Overview

  • 1.1 Product Overview and Scope of Platinum-based Anticancer APIs
  • 1.2 Platinum-based Anticancer APIs Segment by Type
    • 1.2.1 Global Platinum-based Anticancer APIs Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Cisplatin
    • 1.2.3 Carboplatin
    • 1.2.4 Oxaliplatin
    • 1.2.5 Nedaplatin
    • 1.2.6 Others
  • 1.3 Platinum-based Anticancer APIs Segment by Application
    • 1.3.1 Global Platinum-based Anticancer APIs Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Testicular Cancer
    • 1.3.3 Osteosarcoma
    • 1.3.4 Breast Cancer
    • 1.3.5 Esophageal Cancer
    • 1.3.6 NSCLC
    • 1.3.7 Other
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Platinum-based Anticancer APIs Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Platinum-based Anticancer APIs Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Platinum-based Anticancer APIs Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Platinum-based Anticancer APIs Market by Region
    • 1.5.1 Global Platinum-based Anticancer APIs Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)
    • 1.5.5 China Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)
    • 1.5.5 India Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Platinum-based Anticancer APIs Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Platinum-based Anticancer APIs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Platinum-based Anticancer APIs Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Platinum-based Anticancer APIs Production Sites, Area Served, Product Types
  • 2.6 Platinum-based Anticancer APIs Market Competitive Situation and Trends
    • 2.6.1 Platinum-based Anticancer APIs Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Platinum-based Anticancer APIs Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Platinum-based Anticancer APIs Market Share by Region (2016-2021)
  • 3.2 Global Platinum-based Anticancer APIs Revenue Market Share by Region (2016-2021)
  • 3.3 Global Platinum-based Anticancer APIs Production, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Platinum-based Anticancer APIs Production
    • 3.4.1 North America Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
    • 3.4.2 North America Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Platinum-based Anticancer APIs Production
    • 3.5.1 Europe Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
    • 3.5.2 Europe Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Platinum-based Anticancer APIs Production
    • 3.6.1 China Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
    • 3.6.2 China Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 India Platinum-based Anticancer APIs Production
    • 3.7.1 India Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
    • 3.7.2 India Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Platinum-based Anticancer APIs Consumption by Region

  • 4.1 Global Platinum-based Anticancer APIs Consumption by Region
    • 4.1.1 Global Platinum-based Anticancer APIs Consumption by Region
    • 4.1.2 Global Platinum-based Anticancer APIs Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Platinum-based Anticancer APIs Consumption by Country
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Platinum-based Anticancer APIs Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Platinum-based Anticancer APIs Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Platinum-based Anticancer APIs Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Platinum-based Anticancer APIs Production Market Share by Type (2016-2021)
  • 5.2 Global Platinum-based Anticancer APIs Revenue Market Share by Type (2016-2021)
  • 5.3 Global Platinum-based Anticancer APIs Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Platinum-based Anticancer APIs Consumption Market Share by Application (2016-2021)
  • 6.2 Global Platinum-based Anticancer APIs Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Jiangsu Hengrui Medicine
    • 7.1.1 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Corporation Information
    • 7.1.2 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Portfolio
    • 7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Jiangsu Hengrui Medicine Main Business and Markets Served
    • 7.1.5 Jiangsu Hengrui Medicine Recent Developments/Updates
  • 7.2 Nanjing Pharmaceutical Factory
    • 7.2.1 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Corporation Information
    • 7.2.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Portfolio
    • 7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 Nanjing Pharmaceutical Factory Main Business and Markets Served
    • 7.2.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
  • 7.3 Qilu Pharmaceutical
    • 7.3.1 Qilu Pharmaceutical Platinum-based Anticancer APIs Corporation Information
    • 7.3.2 Qilu Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
    • 7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Qilu Pharmaceutical Main Business and Markets Served
    • 7.3.5 Qilu Pharmaceutical Recent Developments/Updates
  • 7.4 Neptunus
    • 7.4.1 Neptunus Platinum-based Anticancer APIs Corporation Information
    • 7.4.2 Neptunus Platinum-based Anticancer APIs Product Portfolio
    • 7.4.3 Neptunus Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Neptunus Main Business and Markets Served
    • 7.4.5 Neptunus Recent Developments/Updates
  • 7.5 Hisun
    • 7.5.1 Hisun Platinum-based Anticancer APIs Corporation Information
    • 7.5.2 Hisun Platinum-based Anticancer APIs Product Portfolio
    • 7.5.3 Hisun Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Hisun Main Business and Markets Served
    • 7.5.5 Hisun Recent Developments/Updates
  • 7.6 Jiangsu HaiCi biological pharmaceutical
    • 7.6.1 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Corporation Information
    • 7.6.2 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Portfolio
    • 7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Jiangsu HaiCi biological pharmaceutical Main Business and Markets Served
    • 7.6.5 Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates
  • 7.7 Kunming Guiyan Pharmaceutical
    • 7.7.1 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Corporation Information
    • 7.7.2 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
    • 7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Kunming Guiyan Pharmaceutical Main Business and Markets Served
    • 7.7.5 Kunming Guiyan Pharmaceutical Recent Developments/Updates
  • 7.8 Lingnan Pharmacy
    • 7.8.1 Lingnan Pharmacy Platinum-based Anticancer APIs Corporation Information
    • 7.8.2 Lingnan Pharmacy Platinum-based Anticancer APIs Product Portfolio
    • 7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Lingnan Pharmacy Main Business and Markets Served
    • 7.7.5 Lingnan Pharmacy Recent Developments/Updates
  • 7.9 Jinzhou Jiutai Pharmaceutical
    • 7.9.1 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Corporation Information
    • 7.9.2 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
    • 7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Jinzhou Jiutai Pharmaceutical Main Business and Markets Served
    • 7.9.5 Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
  • 7.10 Nanjing Hairun Pharmaceutical
    • 7.10.1 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Corporation Information
    • 7.10.2 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
    • 7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Nanjing Hairun Pharmaceutical Main Business and Markets Served
    • 7.10.5 Nanjing Hairun Pharmaceutical Recent Developments/Updates
  • 7.11 Simcere
    • 7.11.1 Simcere Platinum-based Anticancer APIs Corporation Information
    • 7.11.2 Simcere Platinum-based Anticancer APIs Product Portfolio
    • 7.11.3 Simcere Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.11.4 Simcere Main Business and Markets Served
    • 7.11.5 Simcere Recent Developments/Updates
  • 7.12 Teva
    • 7.12.1 Teva Platinum-based Anticancer APIs Corporation Information
    • 7.12.2 Teva Platinum-based Anticancer APIs Product Portfolio
    • 7.12.3 Teva Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.12.4 Teva Main Business and Markets Served
    • 7.12.5 Teva Recent Developments/Updates
  • 7.13 Cipla
    • 7.13.1 Cipla Platinum-based Anticancer APIs Corporation Information
    • 7.13.2 Cipla Platinum-based Anticancer APIs Product Portfolio
    • 7.13.3 Cipla Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.13.4 Cipla Main Business and Markets Served
    • 7.13.5 Cipla Recent Developments/Updates
  • 7.14 Heraeus
    • 7.14.1 Heraeus Platinum-based Anticancer APIs Corporation Information
    • 7.14.2 Heraeus Platinum-based Anticancer APIs Product Portfolio
    • 7.14.3 Heraeus Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.14.4 Heraeus Main Business and Markets Served
    • 7.14.5 Heraeus Recent Developments/Updates
  • 7.15 Hospira(Pfizer)
    • 7.15.1 Hospira(Pfizer) Platinum-based Anticancer APIs Corporation Information
    • 7.15.2 Hospira(Pfizer) Platinum-based Anticancer APIs Product Portfolio
    • 7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.15.4 Hospira(Pfizer) Main Business and Markets Served
    • 7.15.5 Hospira(Pfizer) Recent Developments/Updates
  • 7.16 Taj Pharmaceuticals
    • 7.16.1 Taj Pharmaceuticals Platinum-based Anticancer APIs Corporation Information
    • 7.16.2 Taj Pharmaceuticals Platinum-based Anticancer APIs Product Portfolio
    • 7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.16.4 Taj Pharmaceuticals Main Business and Markets Served
    • 7.16.5 Taj Pharmaceuticals Recent Developments/Updates
  • 7.17 Umicore Precious Metals Chemistry
    • 7.17.1 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Corporation Information
    • 7.17.2 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Portfolio
    • 7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.17.4 Umicore Precious Metals Chemistry Main Business and Markets Served
    • 7.17.5 Umicore Precious Metals Chemistry Recent Developments/Updates

8 Platinum-based Anticancer APIs Manufacturing Cost Analysis

  • 8.1 Platinum-based Anticancer APIs Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Platinum-based Anticancer APIs
  • 8.4 Platinum-based Anticancer APIs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Platinum-based Anticancer APIs Distributors List
  • 9.3 Platinum-based Anticancer APIs Customers

10 Market Dynamics

  • 10.1 Platinum-based Anticancer APIs Industry Trends
  • 10.2 Platinum-based Anticancer APIs Growth Drivers
  • 10.3 Platinum-based Anticancer APIs Market Challenges
  • 10.4 Platinum-based Anticancer APIs Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Platinum-based Anticancer APIs by Region (2022-2027)
  • 11.2 North America Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)
  • 11.4 China Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)
  • 11.5 India Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Platinum-based Anticancer APIs
  • 12.2 North America Forecasted Consumption of Platinum-based Anticancer APIs by Country
  • 12.3 Europe Market Forecasted Consumption of Platinum-based Anticancer APIs by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Platinum-based Anticancer APIs by Region
  • 12.5 Latin America Forecasted Consumption of Platinum-based Anticancer APIs by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Platinum-based Anticancer APIs by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Platinum-based Anticancer APIs by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Platinum-based Anticancer APIs by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Platinum-based Anticancer APIs by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    Summary:
    Get latest Market Research Reports on Platinum-based Anticancer APIs. Industry analysis & Market Report on Platinum-based Anticancer APIs is a syndicated market report, published as Global Platinum-based Anticancer APIs Market Research Report 2021. It is complete Research Study and Industry Analysis of Platinum-based Anticancer APIs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,296.80
    3,445.20
    4,593.60
    2,679.60
    4,019.40
    5,359.20
    438,741.00
    658,111.50
    877,482.00
    241,773.00
    362,659.50
    483,546.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report